Revenue
$2.90B
Gross Margin
+71.0%
Operating Margin
+17.5%
Net Margin
+10.4%
Income statement waterfall for Insulet (PODD) — TTM through Q1 2026
Net income: $302.80M
Margin breakdown for Insulet (PODD) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $2.90B | $2.90B |
| Cost of Revenue | −$840.90M | $2.06B |
| Gross Profit | $2.06B | $2.06B |
| Operating Expenses | −$1.55B | $507.20M |
| Operating Income | $507.20M | $507.20M |
| Other Income / Expense | −$102.80M | $404.40M |
| Pre-tax Income | $404.40M | $404.40M |
| Income Tax | −$101.50M | $302.90M |
| Net Income | $302.80M | $302.80M |
- Revenue$2.90B
- Cost of Revenue−$840.90M
- Gross Profit$2.06B
- Operating Expenses−$1.55B
- Operating Income$507.20M
- Other Income / Expense−$102.80M
- Pre-tax Income$404.40M
- Income Tax−$101.50M
- Net Income$302.80M
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Insulet (PODD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement